Profile
CEMI DHR-PB TMO DHR IQV A
Company Name Chembio Diagnostics, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $16.71M $916.76B $234.95B $194.50B $45.86B $41.70B
Employees 0.19K 79.00K 122.00K 61.00K 88.00K 17.40K
CEO Mr. Richard L. Eberly Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
CEMI DHR-PB TMO DHR IQV A
Quant Rating Score 4 5 3 3 3 3
Quant Rating Buy Strong Buy Neutral Neutral Neutral Neutral
Trading
CEMI DHR-PB TMO DHR IQV A
Last Close $0.455 $1261.26 $615.07 $269.31 $251.55 $142.92
High 52 $0.46 $1261.26 $621.77 $280.76 $259.1 $154.64
Low 52 $0.46 $1261.26 $431.41 $185.1 $177.16 $101.17
Price vs. 52 Week High -1.09 % 0 % -1.08 % -4.08 % -2.91 % -7.58 %
Price vs. 52 Week Low -1.09 % 0 % 42.57 % 45.49 % 41.99 % 41.27 %
Total Return
CEMI DHR-PB TMO DHR IQV A
1 Month Return 0 % 0 % -1.08 % -4.08 % 1.28 % 0.04 %
3 Month Return 0 % 0 % 8.29 % 4.87 % 14.82 % 9.59 %
6 Month Return 0 % 0 % 6.72 % 5.25 % -0.36 % 2.78 %
9 Month Return 0 % 0 % 23.97 % 20.51 % 15.97 % 10.97 %
YTD Return 0 % 0 % 15.88 % 16.41 % 8.72 % 2.8 %
1 Year Return 0 % 0 % 10.38 % 1.4 % 12.13 % 17.23 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CEMI DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.39 % 0.24 % 0.39 % - 0.65 %
Dividend Paid and Capex Coverage Ration (TTM) -8.75 % 3.16 % 4.82 % 3.04 % 3.98 % 2.79 %
Dividend Per Share (TTM) - 1.05 % 1.48 % 1.05 % - 0.93 %
Payout Ratio (TTM) - 17.87 % 8.92 % 18.46 % - 19.25 %
Growth
CEMI DHR-PB TMO DHR IQV A
Asset Growth -14.53 % 0.16 % 1.62 % 0.16 % 5.3 % 2.19 %
Gross Profit Growth 301.57 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth 30.91 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year -2.14 % 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year 1.89 % 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year -37.97 % 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth 15.01 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth 31.3 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share -18.83 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share -85.03 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share -913.2 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth 15.01 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) 58.9 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG 2.19 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG -27.63 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG -648.15 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth 31.43 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth 31.43 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -48.06 % 5.14 % 7.9 % 5.14 % 8.21 % 12.05 %
Share Holder 3 Year Equity Growth Per Share -48.33 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share -31.12 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share -57.84 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth - -1.19 % 16.73 % -1.19 % - 7.8 %
Dividend 3 Year Growth Per Share - 28 % 59.21 % 28 % - 25.46 %
Dividend 5 Year Growth Per Share - 80.2 % 104.77 % 80.2 % - 51.49 %
Dividend 10 Year Growth Per Share - 1389.16 % 125.8 % 1389.16 % - 97.03 %
Debt Growth -3 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth 56.8 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
CEMI DHR-PB TMO DHR IQV A
Gross Profit Margin TTM 20.19 % 58.45 % 41.29 % 59.41 % 29.7 % 54.86 %
Return on Assets TTM -37.2 % 5.33 % 6.32 % 5.35 % 5.39 % 12.85 %
Return on Equity TTM -89.47 % 8.42 % 13.45 % 8.04 % 22.79 % 23.4 %
Return on Capital Employed TTM -87.52 % 7.39 % 8.59 % 6.21 % 10.68 % 17.47 %
Net Income Per EBT TTM 100.15 % 83.98 % 90.7 % 99.88 % 94.99 % 91.75 %
EBT Per Ebit TTM 113.99 % 94.74 % 95.32 % 94.37 % 70.93 % 102.39 %
EBIT Per Revenue TTM -42.21 % 21.3 % 16.99 % 21.13 % 13.9 % 23.15 %
Cash Flow To Debt Ratio TTM -50.61 % 36.11 % 26.4 % 35.4 % 18.4 % 60.91 %
Receivables Turnover TTM 2.58 7.76 4.49 6.4 4.61 5.3
Payables Turnover TTM 11.54 6.49 9.76 5.21 3.23 5.9
Inventory Turnover TTM 5 4.12 4.78 3.21 - 3
Fixed Asset Turnover TTM 352.21 % 463.28 % 456.22 % 367.49 % 1979.04 % 449.31 %
Asset Turnover TTM 77.21 % 31.45 % 42.99 % 26.87 % 57.58 % 59.09 %
Operating Cash Flow Per Share TTM -0.52 9.27 24.47 8.74 13.39 6.16
Free Cash Flow Per Share TTM -0.58 7.39 20.85 6.92 10.03 4.89
Cash Per Share TTM 74.81 % 937.04 % 2312.57 % 321.85 % 920.97 % 613.45 %
Operating Cash Flow Sales Ratio TTM -26.26 % 26.52 % 22.08 % 30.55 % 16.05 % 27.49 %
Free Cash Flow Operating Cash Flow Ratio TTM 111.43 % 79.76 % 85.18 % 79.14 % 74.88 % 79.34 %
Cash Flow Coverage Ratios TTM -50.61 % 36.11 % 26.4 % 35.4 % 18.4 % 60.91 %
Price To Free Cash Flows Ratio TTM -1.18 35.06 29.51 38.12 25.1 29.43
Price To Operating Cash Flows Ratio TTM -0.87 29.05 25.13 30.81 18.78 23.21
Price Cash Flow Ratio TTM -0.87 29.05 25.13 30.81 18.78 23.21
Income Statement (TTM)
CEMI DHR-PB TMO DHR IQV A
Revenue $0.05B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $0.01B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio 20.19% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $-0.01B $7.76B $10.72B $7.76B $3.21B $1.71B
Net Income $-0.02B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -0.96 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
CEMI DHR-PB TMO DHR IQV A
Long Term Debt $0.01B $17.66B $31.31B $17.66B $12.96B $2.74B
Total Liabilities $0.04B $31B $51.88B $31B $20.57B $4.92B
Total Equity $0.02B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $0.03B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $0.06B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
CEMI DHR-PB TMO DHR IQV A
Net Income $-0.02B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-0.82B $-0.52B $-0.82B $0B $-0.27B
Operating Cash Flow $-0.01B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 142.92
ACRS Aclaris Therapeutics, Inc. 1.18
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 1.91
AWH Aspira Women's Health Inc. 1.03
BDSX Biodesix, Inc. 1.96
BIAF bioAffinity Technologies, Inc. 1.5
BIAFW bioAffinity Technologies, Inc. 1.19
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.49
BNR Burning Rock Biotech Limited 5.295
CDNA CareDx, Inc 30.73
CHEK Check-Cap Ltd. 1.885
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 197.75
CSTL Castle Biosciences, Inc. 29.67
DGX Quest Diagnostics Incorporated 156.97
DHR Danaher Corporation 269.31
DHR-PA Danaher Corporation 1841.01
ETFs With Exposure to CEMI
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 123.58
Unlock